financetom
Business
financetom
/
Business
/
Fiera Capital Q4 Adjusted Earnings Fall, Miss Analyst Expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fiera Capital Q4 Adjusted Earnings Fall, Miss Analyst Expectations
Feb 26, 2025 5:25 AM

07:58 AM EST, 02/26/2025 (MT Newswires) -- Fiera Capital ( FRRPF ) reported on Wednesday lower adjusted earnings for the fourth quarter that fell short of analyst expectations.

The asset management firm booked adjusted earnings of $22.8 million, or $0.21 per share, below the FactSet analyst consensus non-GAAP EPS forecast of $0.38 and down from $50.2 million, or $0.47 per share, recorded a year ago.

"2024 was a strong year for financial markets with investors spending much of the year focused on a soft economic landing and aggressive rate cuts," said Jean-Guy Desjardins, Fiera's chair of the board and global CEO.

Assets under management (AUM) totaled an average of $166.6 billion, increasing from $158.4 billion. Total revenue declined to $184.0 million from $211.0 million.

"The strength in financial markets in 2024, along with a shift in asset mix towards private markets AUM and higher-fee strategies, resulted in growth in base management fees for the year," said Lucas Pontillo, Fiera's executive director and global CFO. "However, a reduction in performance fees resulted in lower total revenues producing an adjusted EBITDA margin of 28.4% for 2024."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved